WASHINGTON, April 8 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Lovega LLC dba Pink Pony Peptides from its Center for Drug Evaluation and Research:

* * *

Recipient: Susan Vega, Lovega LLC dba Pink Pony Peptides, 9314 Forest Hill Blvd 902, Wellington, FL 33411, United States, help@pinkponypeptides.com

Issuing Office: Center for Drug Evaluation and Research (CDER), United States